company background image
ORIONPHARM logo

Orion Pharma DSE:ORIONPHARM Stock Report

Last Price

৳70.90

Market Cap

৳16.6b

7D

-1.3%

1Y

-10.9%

Updated

18 Jun, 2024

Data

Company Financials

Orion Pharma Limited

DSE:ORIONPHARM Stock Report

Market Cap: ৳16.6b

ORIONPHARM Stock Overview

Engages in the discovery, development, manufacturing, and marketing of pharmaceutical products in Bangladesh.

ORIONPHARM fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance1/6
Financial Health2/6
Dividends2/6

Orion Pharma Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Orion Pharma
Historical stock prices
Current Share Price৳70.90
52 Week High৳91.80
52 Week Low৳61.30
Beta-0.57
1 Month Change2.31%
3 Month Change6.94%
1 Year Change-10.93%
3 Year Change19.76%
5 Year Change117.48%
Change since IPO13.14%

Recent News & Updates

Recent updates

Shareholder Returns

ORIONPHARMBD PharmaceuticalsBD Market
7D-1.3%1.1%0.1%
1Y-10.9%-24.1%-26.6%

Return vs Industry: ORIONPHARM exceeded the BD Pharmaceuticals industry which returned -24.1% over the past year.

Return vs Market: ORIONPHARM exceeded the BD Market which returned -26.6% over the past year.

Price Volatility

Is ORIONPHARM's price volatile compared to industry and market?
ORIONPHARM volatility
ORIONPHARM Average Weekly Movement7.0%
Pharmaceuticals Industry Average Movement6.8%
Market Average Movement5.3%
10% most volatile stocks in BD Market7.7%
10% least volatile stocks in BD Market3.3%

Stable Share Price: ORIONPHARM has not had significant price volatility in the past 3 months.

Volatility Over Time: ORIONPHARM's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of BD stocks.

About the Company

FoundedEmployeesCEOWebsite
19652,716Zareen Karimwww.orionpharmabd.com

Orion Pharma Limited engages in the discovery, development, manufacturing, and marketing of pharmaceutical products in Bangladesh. The company produces products in various dosage forms, including tablets, capsules, syrups, suspensions, injections, and dry powder for syrup/ suspension in various therapeutic groups like anticancer, antibiotics, anti diabetics, anxiolytics, diuretics, cardiovascular drugs, etc. It also provides various vaccines and health-related consumer products. The company was formerly known as Orion Laboratories Limited and changed its name to Orion Pharma Limited in October 2010.

Orion Pharma Limited Fundamentals Summary

How do Orion Pharma's earnings and revenue compare to its market cap?
ORIONPHARM fundamental statistics
Market cap৳16.59b
Earnings (TTM)৳455.46m
Revenue (TTM)৳11.50b

36.4x

P/E Ratio

1.4x

P/S Ratio

Is ORIONPHARM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ORIONPHARM income statement (TTM)
Revenue৳11.50b
Cost of Revenue৳9.33b
Gross Profit৳2.17b
Other Expenses৳1.71b
Earnings৳455.46m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.95
Gross Margin18.85%
Net Profit Margin3.96%
Debt/Equity Ratio95.8%

How did ORIONPHARM perform over the long term?

See historical performance and comparison

Dividends

1.4%

Current Dividend Yield

51%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.